Fundraising FoxSunstone Capital — 2013 Investments
1 investments dated 2013 · listed companies and verified rows first · show all
JenaValvejenavalve.comJul 2013 · $62.5M
JenaValve develops transcatheter aortic valve replacement systems to treat severe aortic regurgitation and aortic stenosis.
Digital HealthHealthtechMedical DevicesIrvine, US
Hans Figulla(Director)Markus FerrariVictoria Carr-Brendel(Executive Officer, Director)David Drachman(Executive Officer, Director)
.jpg)
BoardArnd Kaltofen(Director)inErik Amble(Director)
Co-investorsAndera PartnersBain Capital Life SciencesRosetta Capital Ltd.VI PartnersAtlas VentureGimv+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.